San Mateo-based
EndoGastric Solutions, a developer of reconstructive treatments for gastroesophageal reflux disease (GERD), has raised $30M in a new funding round, the company said this week. The funding came from existing investors, including dvanced Technology Ventures, Canaan Partners, Chicago Growth Partners, De Novo Ventures, Foundation Medical Partners, Oakwood Medical Investors and Radius Ventures. EndoGastric said the funding was a Series G round.
posted on Friday, May 9, 2014 (Link to more information)
Related companies:
EndoGastric Solutions FKA EsophyX
Related stories:
> Endogastric Solutions Gains $13M More
> EndoGastric Solutions Gets $21.5M
> EndoGastric Solutions Raises $30M
> Aravo Solutions Lands $10M
> Jacent Technologies Lands $6.7M
silicontap.com Home